<DOC>
	<DOCNO>NCT02761499</DOCNO>
	<brief_summary>This prospective , single arm , multi-center , post-approval study design evaluate short long term clinical performance safety subject receive primary total hip arthroplasty ( THA ) U-Motion II+ Acetabular System UTF Reduced Stem .</brief_summary>
	<brief_title>Post Approval Study Commercially Available U-Motion II+ Acetabular System UTF Reduced Stem</brief_title>
	<detailed_description>This prospective , single arm , multi-center , post-approval study design evaluate short long term clinical performance safety subject receive primary total hip arthroplasty ( THA ) U-Motion II+ Acetabular System UTF Reduced Stem . The acetabular femoral component uncemented . Study outcomes analyze publish 1 . ) enrol implanted subject complete 6-week follow , 2 . ) implant subject complete 2-year follow , 3 . ) conclusion study . It anticipate 200 subject enrol 5 site . The subject evaluate predetermined interval : baseline , procedure/ discharge 6 week , 3 month , 6 month , 12 month , 24 month post treatment primary analysis annually 5 year device survivorship . The estimate study duration first enrollment completion final report expect approximately 7 year . This study conduct 5 investigational site United States previous clinical research experience adequate population orthopedic patient require primary total hip arthroplasty .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>Subjects must meet follow criterion consider inclusion study . 1 . Subject 18 75 year age 2 . Subject indicated unilateral bilateral total hip arthroplasty ( THA ) base approve labeling device 3 . Subject history previous prosthetic replacement device orthopedic surgery operative hip 4 . Subject willing able provide inform consent participate study ; 5 . Subject willing able understand purpose study , his/her role , available return clinic/hospital require followup visit ; Subjects exclude , opinion Investigator , subject qualify base approve labeling requirement Subject Inclusion criterion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>